Sanj K. Patel
Net Worth

Last updated:

What is Sanj K. Patel net worth?

The estimated net worth of Mr. Sanj K. Patel is at least $24,501,962 as of 6 Nov 2024. He owns shares worth $2,625,183 as insider, has earned $11,866,779 from insider trading and has received compensation worth at least $10,010,000 in Kiniksa Pharmaceuticals, Ltd..

What is the salary of Sanj K. Patel?

Mr. Sanj K. Patel salary is $1,430,000 per year as Chief Executive Officer & Chairman in Kiniksa Pharmaceuticals, Ltd..

How old is Sanj K. Patel?

Mr. Sanj K. Patel is 55 years old, born in 1970.

What stocks does Sanj K. Patel currently own?

As insider, Mr. Sanj K. Patel owns shares in one company:

Company Title Shares Price per share Total value
Kiniksa Pharmaceuticals, Ltd. (KNSA) Chief Executive Officer & Chairman 79,551 $33 $2,625,183

What does Kiniksa Pharmaceuticals, Ltd. do?

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.

KNSA logo
KNSA
Kiniksa Pharmaceuticals, Ltd.
$33

Sanj K. Patel insider trading

Kiniksa Pharmaceuticals, Ltd.

Mr. Sanj K. Patel has made 14 insider trades between 2018-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 250,030 units of KNSA stock on 12 Oct 2020. As of 6 Nov 2024 he still owns at least 79,551 units of KNSA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Share Option 89,561 $1.59 $142,402
Sale
Class A Ordinary Share 89,561 $23 $2,059,903
Option
Class A Ordinary Share 89,561 $1.59 $142,402
Option
Restricted Share Unit 6,569 N/A N/A
Option
Class A Ordinary Share 6,569 N/A N/A
Option
Restricted Share Unit 9,992 N/A N/A
Option
Class A Ordinary Share 16,474 N/A N/A
Option
Restricted Share Unit 6,482 N/A N/A
Option
Restricted Share Unit 9,992 N/A N/A
Option
Class A Common Share 9,992 N/A N/A
Option
Class A Common Share 6,482 N/A N/A
Option
Restricted Share Unit 6,482 N/A N/A
Sale
Class A Common Share 65,012 $21.02 $1,366,552
Sale
Class A Common Share 5,582 $21 $117,222
Sale
Class A Common Share 3,336 $22 $73,392
Sale
Class A Common Share 9,406 $21.31 $200,442
Option
Class A Common Share 6,569 N/A N/A
Option
Restricted Share Unit 6,569 N/A N/A
Option
Restricted Share Unit 9,992 N/A N/A
Option
Class A Common Share 9,992 N/A N/A
Option
Class A Common Share 9,992 N/A N/A
Option
Restricted Share Unit 9,992 N/A N/A
Option
Class A Common Share 12,002 N/A N/A
Option
Restricted Share Unit 12,002 N/A N/A
Option
Class A Common Share 6,569 N/A N/A
Option
Restricted Share Unit 6,569 N/A N/A
Option
Class A Common Share 6,569 N/A N/A
Option
Restricted Share Unit 6,569 N/A N/A
Option
Restricted Share Unit 18,555 N/A N/A
Option
Class A Common Share 18,555 N/A N/A
Option
Restricted Share Unit 6,569 N/A N/A
Option
Class A Common Share 6,569 N/A N/A
Sale
Class A Common Shares 2,737 $11.54 $31,571
Sale
Class A Common Shares 2,737 $23.07 $63,129
Option
Share Option 1,600 N/A N/A
Option
Class A Common Shares 1,600 N/A N/A
Option
Class A Common Shares 20,401 $23.04 $470,039
Option
Share Option 20,401 $23.04 $470,039
Sale
Class A Common Shares 43,970 $23.06 $1,013,948
Sale
Class A Common Shares 43,970 $23.06 $1,013,948
Sale
Class A Common Shares 9,452 $0.8 $7,514
Option
Share Option 4,924 $1.59 $7,829
Option
Class A Common Shares 4,924 N/A N/A
Option
Class A Common Shares 150,700 $21.02 $3,167,714
Option
Share Option 150,700 N/A N/A
Sale
Class A Common Shares 250,030 $21.02 $5,255,631
Sale
Class A Common Shares 250,030 N/A N/A
Option
Share Option 872 $1.59 $1,386
Sale
Class A Common Shares 1,542 $0.8 $1,226
Option
Class A Common Shares 872 $1.59 $1,386
Sale
Class A Common Shares 33,115 $20 $662,300
Purchase
Series C Preferred Shares 63,922 N/A N/A

Kiniksa Pharmaceuticals, Ltd. key executives

Kiniksa Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC: